Deaths Prompt Warnings On Rituxan

Law360, New York (December 19, 2006, 12:00 AM EST) -- The U.S. Food and Drug Administration and the drug makers are warning the public that two patients who have taken non-Hodgkins lymphoma and rheumatoid arthritis drug Rituxan have died from a rare nervous system disease.

The FDA said Monday that the patients were taking the drug for systemic lupus erythematosus and developed progressive multifocal leukoencephalopathy or PML, which is a fatal viral infection of the central nervous system. The patients reported the infection as late as a year after their last doses of the drug....
To view the full article, register now.